|Description||Landiolol is an ultra-short-acting Beta 1 adrenergic receptor antagonist using for managing supraventricular tachyarrhythmias in sepsis. It is also used as an anti-arrhythmic agent.|
|Synonyms||Ono 1101; UNII-62NWQ924LH; [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-[4-[(2S)-2-hydroxy-3-[2-(morpholine-4-carbonylamino)ethylamino]propoxy]phenyl]propanoate;144481-98-1(hydrochloride)|
|Solubility||Soluble in DMSO|
|Quality Standard||In-house standard|
|Shelf Life||2 month in rt, long time|
|Current Developer||Originator Ono Pharmaceutical|
Nolomirole is a Alpha 2 adrenergic receptor and Dopamine D2 receptor agonist. Nolomirole can attenuate the heart failure signs in the monocrotaline-induced cong...
Tolazoline is a non-selective competitive α-adrenergic receptor antagonist.
This active molecular is a selective α1D Adrenergic Receptor antagonist. ( Ki value of 1.1 nM, 200 fold selective over α1A and 800 fold selective over α1B). TAK...
Salbutamol is a short-acting agonist that specifically targets β2-adrenergic receptor to alleviate bronchospasm in conditions such as asthma and chronic obstruc...
Timolol Maleate is a non-selective, beta-adrenergic receptor antagonist for β1/β2 with Ki of 1.97 nM/2.0 nM.
Penbutolol is a sympathomimetic drug used to treat mild to moderate high blood pressure by binding to both beta-1 adrenergic receptors and beta-2 adrenergic rec...
Fiduxosin is a potent antagonist of α1-adrenoceptor, with Ki= 0.160 nM, 24.9 nM, and 0.920 nM for α1a-, α1b-, and α1d-adrenoceptors, respectively. Fiduxosin was...
AdTx1 is a high affinity, selective and non-competitive α1A adrenoceptor antagonist with Ki value of 0.35 nM. It is a 65 amino-acid peptide originally isolated ...
Dobutamine is a sympathomimetic drug used in the treatment of heart failure and cardiogenic shock. Its primary mechanism is direct stimulation of β1 receptors o...
ICI 118551 hydrochloride
ICI 118551 hydrochloride is a highly selective β2 adrenergic antagonist (Ki values are 1.2, 120 and 257 nM for β2, β1 and β3 receptors respectively), inhibited ...
GYKI-16084 is a postsynaptic alpha2-blocker with the potential to treat benign prostatic hyperplasia.
Trecadrine, a new β3-adrenergic agonist, decreases fat content and increases gastrocnemius muscle UCP2 gene expression in a diet-induced obesity model.
ST 91 is an α2-adrenoceptor agonist that displays ~ 120-fold selectivity for α2 receptors over α1 receptors. It acts predominantly at non-α2A-adrenoceptors whic...
Salmeterol Xinafoate is a long-acting β2-adrenergic receptor agonist with anti-inflammatory effects, used in the treatment of asthma symptoms and chronic obstru...
Guanfacine Hydrochloride is a centrally acting alpha-2 adrenergic agonist that has been available as an FDA-approved hypotensive agent for more than two decades...
L-α-Methyl DOPA Hydrate
L-α-Methyl DOPA Hydrate is an alpha-adrenergic agonist used as a sympatholytic or antihypertensive.
Brombuterol is found to be a novel β-adrenergic agonist that can increase the meat-to-fat ratio but it is banned in animal feeds.
(R,R)-Formoterol is a long acting beta-adrenoceptor agonist acts as a novel highly β2-selective adrenergic agonist and holds promise as a β2-agonist that could ...
Yohimbine, an indolalkylamine alkaloid, blocks presynaptic alpha-2 adrenergic receptors. IC50= 0.6 μM Ki: 1.05 nM, alphaα2Areceptor
CL-316243 is a potent and highly selective β3-adrenoceptor agonist (EC50 = 3 nM) with > 10000-fold selective over β1 and β2 receptors. CL 316243 possesses anti-...